We find that the DEK::NUP214 AML GRN is related to that of mutant NPM1 AML, but also displays an elevated leukemic stem cell signature, suggesting overlapping and unique therapeutic vulnerabilities. Here, NPM1 is linked to acute myeloid leukemia.